Mast Cells: Accessory Cells Which Potentiate Fibrosis

References

• Claman H. N. On scleroderma: Mast cells, endothelial cells, and fibre-blasts. JAMA 1989; 262: 1206–1209
   Google Scholar
• Dabbous M. K., Walker R., Haney L., Carter L. M., Nicholson G. L., Woolley D. E. Mast cells and matrix degradation at sites of tumor invasion in rat mammary adenocarcinoma. Br. J. Cancer 1986; 54: 459–465
   PubMed Web of Science ®Google Scholar
• Bromley M., Fischer W. D., Woolley D. E. Mast cells at the site of cartilage erosion in the rheumatoid joint. Ann. Rheum. Dis. 1984; 43: 76–79
   PubMedGoogle Scholar
• Atkins F. M., Clark R. A. F. Mast cells and fibrosis. Arch. Dermatol. 1987; 123: 191–193
   PubMedGoogle Scholar
• Osborn L. Leukocyte adhesion to endothelium in inflammation. Cell 1990; 62: 3–6
   PubMed Web of Science ®Google Scholar
• Kyan-Aung U., Haskard D. O., Poston R. N. Endothelial leukocyte adhesion molecule-1 mediate the adhesion of eosinophils to endothelial cells in vitro and are expressed by endothelium in allergic cutaneous inflammation in vivo. J. Immunol 1991; 146: 521–528
   PubMed Web of Science ®Google Scholar
• Klein L. M-., Lavker R. M., Matis W. L., Murphy G. F. Degranulation of human mast cells induces an endothelial antigen central to leukocyte adhesion. Proc. Natl. Acad. Scl. USA 1989; 86: 8972–8976
   PubMed Web of Science ®Google Scholar
• Meng H., Tonnesen M. G., Marchese M. J., Bahou W. F., Clark R. A., Gruber B. L. Mast cells are potent regulators of endothelial cell adhesion molecules ICAM-1 and VCAM-1. Submitted 1995
   Google Scholar
• Brown S. J., Galli S. J., Gleich G. J., Askenase P. W. Ablation of immunity to Amblyomma americanum by anti-basophil serum: Cooperation between basophils and eosinophils in expression of immunity to extoparasites (ticks) in guinea pigs. J. Immunol. 1982; 129: 790–796
   PubMed Web of Science ®Google Scholar
• Malaviya R., Ross E., Jakschik B. A., Abraham S. N. Mast cell degranulation induced by type 1 fimbriated Escherichia coli in mice. J. Clin. Invest. 1994; 93: 1645–1653
   Google Scholar
• Galli S. J. New concepts about the mast cells. N. Engl. J. Med. 1993; 328: 257–265
   PubMed Web of Science ®Google Scholar
• Gruber B. L., Marchese M. J., Suzuki K., Schwartz L. B., Okada Y., Nagase H., Ramamurthy N. S. Synovial procollagenase activation by human mast cell tryptase dependence upon matrix metalloproteinase 3 activation. J. Clin. Invest. 1989; 84: 1657–1662
   PubMed Web of Science ®Google Scholar
• Dimlich R. V. W., Meineke H. A., Reilly F. D., McCuskey R. S. The fluorescent staining of heparin in mast cells using berberine sulfate: Compatibility with paraformaldehyde or o-pthalaldehyde induced fluorescence and metachromasia. Stain Technology 1980; 55: 217–223
   Web of Science ®Google Scholar
• Enerbäck L. Berberine sulfate binding to mast cell polyanions: A cytofluormetric method for the quantitation of heparin. Histochem. 1974; 42: 301–313
   Google Scholar
• Bergstresser P. R., Tigelaar R. E., Tharp M. D. Conjugated avidin identifies cutaneous rodent and human mast cells. J. Invest. Dermatol. 1984; 83: 214–218
   Google Scholar
• Valent P., Majdic O., Maurer D., Bodger M., Muhm M., Bettelheim P. Further characterization of surface membrane structures expressed on human basophils and mast cells. Int. Arch. Allergy Appl. Immunol. 1990; 91: 198–203
   PubMedGoogle Scholar
• Schwartz L. B. Monoclonal antibodies against human mast cell tryptase demonstrate shared antigenic sites on subunits of tryptase and selective localization of the enzyme to mast cells. J. Immunol. 1985; 134: 526–531
   PubMed Web of Science ®Google Scholar
• Claman H. N. Mast cell depletion in murine chronic graft-versus-host disease. J. Invest. Derm. 1985; 84: 246–248
   Google Scholar
• Galli S. J., Dvorak A. M., Dvorak H. F. Basophils and mast cells: Morphologic insights into their biology, secretory patterns and function. Prog. Allergy 1984; 34: 1–141
   PubMedGoogle Scholar
• Dvorak A. M., Galli S. J., Schulman L., Lichtenstein L. M., Dvorak H. F. Basophil and mast cell degranulation ultrastructural analysis of mechanisms of mediator release. Fed. Proceed 1983; 42: 2510–2515
   PubMedGoogle Scholar
• Craig S. S., Schechter N. M., Schwartz L. B. Ultrastructural analysis of maturing human T and TC mast cells in situ. Lab Invest. 1989; 60: 147
   PubMed Web of Science ®Google Scholar
• Kaminer M. S., Lavker R. M., Walsh R. M., Walsh L. J., Whitaker K., Zweiman B., Murphy G. F. Extracellular localization of human connective tissue mast cell granule contents. J. Invest. Derm. 1991; 96: 857–863
   PubMedGoogle Scholar
• Dvorak A. M. Basophil and Mast Cell Degranulation and Recovery. Blood Cell Biochemistry. Plenum Press, New York 1991, HarrisJ. R.
   Google Scholar
• Valent P., Spanblochl E., Sperr W. R., Sillaber C., Zsebo K., Agis H., Strobl H., Geissler K., Bettelheim P., Lechner K. Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by recombinant human stem cell factor/kit-ligand in long-term culture. Blood 1992; 80: 2237–2245
   PubMed Web of Science ®Google Scholar
• Denburg J. A. Basophil and mast cell lineages in-vitro and in-vivo. Blood 1992; 79: 846–860
   PubMed Web of Science ®Google Scholar
• Dvorak A. M., Newball H. H., Dvorak H. F. Degranulation of basophilic leukocytes in allergic contact dermatitis reactions in man. J. Immunol. 1976; 116: 687–695
   PubMedGoogle Scholar
• Bochner B. S., Peachell P. T., Brown K. E. Adherence of human basophils to cultured umbilical vein endothelial cells. J. Clin. Invest. 1988; 81: 1355–1364
   PubMed Web of Science ®Google Scholar
• Weller P. F., Rand T. H., Goelz S. E., Chi-Rosso G., Lobb R. R. Human eosinophil adherence to vascular endothelium mediated by binding to vascular cell adhesion molecule 1 and endothelial leukocyte adhesion molecule 1. Proc. Natl. Acad. Sci. USA 1991; 88: 7430–7433
   PubMed Web of Science ®Google Scholar
• Bochner B. S., Luscinskas F. W., Gimbrone M. A., Newman S. A., Sterbinshy S. A., Derse-Anthony C., Klunk D., Schleimer R. P. Adhesion of human basophils, eosinophils, and neutrophils to IL-1 activated human vascular endothelial cells: Contributions of endothelial cell adhesion molecules. J. Exp. Med. 1991; 173: 1553–1557
   PubMed Web of Science ®Google Scholar
• Leung Y. M., Pober J. S., Cotran R. S. Expression of endothelial-leukocyte adhesion molecule-1 in elicited phase allergic reactions. J. Clin. Invest. 1991; 87: 1805–1809
   PubMed Web of Science ®Google Scholar
• Greenberg G., Burnstock G. A novel cell-to-cell interaction between mast cells and other cell types. Exp. Cell Res. 1983; 147: 1–13
   PubMedGoogle Scholar
• Baraniuk J. N., Kowalski M. L., Kaliner M. A. Relationships between permeable vessels, nerves, and mast cells in rat cutaneous neurogenic inflammation. J. Appl. Physiol. 1990; 68: 2305–2311
   Google Scholar
• Heard B. E., Dewar A., Corrin B. Apposition of fibroblasts to mast cells and lymphocytes in normal human lung and in cryptogenic fibrosing alveolitis—infrastructure and cell perimeter measurements. J. Pathol 1992; 166: 303–310
   PubMed Web of Science ®Google Scholar
• Kirshenbaum A. S., Kessler S. W., Goff J. P., Metcalfe D. D. Demonstration of the origin of human mast cells from CD34+ bone marrow progenitor cells. J. Immunol. 1991; 146: 1410–1415
   PubMed Web of Science ®Google Scholar
• Galli S. J., Tsai M., Wershil B. K. The c-kit receptor, stem cell factor, and mast cells. What each is teaching us about the others. Am. J. Pathol. 1993; 142: 965–974
   PubMed Web of Science ®Google Scholar
• Galli S. J. New insights into “The riddle of the Mast Cells”: Microenvironmental regulation of mast cell development and phenotypic heterogeneity. Lab. Invest. 1990; 62: 5–33
   PubMed Web of Science ®Google Scholar
• Dastych J., Costa J. J., Thompson H. L., Metcalfe D. D. Mast cell adhesion to fibronectin. Immunology 1991; 73: 478–484
   PubMed Web of Science ®Google Scholar
• Thompson H. L., Burbelo P. D., Yamada Y., Kleinman H. K., Metcalfe D. D. Mast cells chemotax to laminin with enhancement after IgE-mediated activation. J. Immunol. 1989; 143: 4188–4192
   Google Scholar
• Thompson H. L., Burbelo P. D., Metcalfe D. D. Regulation of adhesion of mouse bone-marrow derived mast cells to laminin. J. Immunol. 1990; 145: 3425–3431
   PubMedGoogle Scholar
• Thompson H. L., Burbelo P. D., Yamada Y., Metcalfe D. D. Mast cells synthesize basement membrane components: A potential role in early fibrosis. Clin. Res. 1990; 38: 448A
   Google Scholar
• Ducharme L. A., Weis J. H. Modulation of integrin expression during mast cell differentiation. Eur. J. Immunol. 1992; 22: 2603–2607
   PubMed Web of Science ®Google Scholar
• Gurish M. F., Bell A. M., Smith T. J., Ducharme L. A., Wang R., Weis J. H. Expression of murine β7, a4 and β1 integrin genes by rodent mast cells. J. Immunol. 1992; 149: 1964–1972
   Google Scholar
• Metcalfe D. D., Costa J. J., Burd P. R. Mast cells and basophils. Inflammation: Basic Principles and Clinical Correlates. Raven Press, New York 1992, Second Goldstein JI Gal M. 709725
   Google Scholar
• Hamawy M. M., Mergenhagen S. E., Siraganian R. P. Adhesion molecules as regulators of mast cell and basophil function. Immunol. Today 1994; 15: 62–66
   PubMedGoogle Scholar
• Meininger C. J., Yano H., Rottapel R., Bernstein A., Zsebo K. M., Zetter B. R. The c-kit receptor ligand functions as a mast cell chemoattractant. Blood 1992; 79: 958–963
   PubMed Web of Science ®Google Scholar
• Matsuura N., Zetter B. R. Stimulation of mast cell chemotaxis by interleukin 3. J. Exp. Med. 1989; 170
   Google Scholar
• Gruber B. L., Marchese M. J., Kew R. Transforming growth factor-β1 mediates chemotaxis of mast cells. J. Immunol. 1994; 152: 5860–5867
   PubMed Web of Science ®Google Scholar
• Rennick D., Lee F. D., Yokota T. A cloned MCGF cDNA encodes a multilineage hematopoietic growth-factor: Multiple activities of interleukin 3. J. Immunol. 1985; D4: 910–914
   Google Scholar
• Ihle J. N., Keller J., Oroszlan S. Biological properties of homogeneous interleukin 3. I. Demonstration of WEHI-3 growth-factor activity, mast cell growth-factor activity, P cell-stimulating factor activity and histamine-producing factor activity. J. Immunol. 1983; 131: 282–287
   PubMed Web of Science ®Google Scholar
• Horigome K., Bullock E. D., Johnson E. M. Effects of nerve growth factor on rat peritoneal mast cells. J. Biol. Chem. 1994; 269: 2695–2702
   PubMed Web of Science ®Google Scholar
• Kirshenbaum A. S., Goff J. P., Kessler S. W., Mican J. M., Zsebo K. M., Metcalfe D. D. Effect of IL-3 and stem cell factor on the appearance of human basophils and mast cells from CD34+ pluripotent progenitor cells. J. Immunol. 1992; 148: 772–777
   PubMed Web of Science ®Google Scholar
• Swieter M., Mergenhagen S. E., Siraganian R. P. Microenvironmental factors that influence mast cell phenotype and function. Proc. Soc. Exp. Biol. Med. 1992; 199: 22–33
   Google Scholar
• Furitsu T., Saito H., Dvorak A. M., Schwartz L. B., Irani A. M., Burdick J. F., Ishizaka K., Ishizaka T. Development of human mast cells in vitro. Proc. Nail. Acad. Sci. USA 1989; 86: 10039–10043
   PubMed Web of Science ®Google Scholar
• Irani A. A., Craig S. S., Nilsson G., Ishizaka T., Schwartz L. B. Characterization of human mast cells developed in vitro from fetal liver cells cocultured with murine 3T3 fibroblasts. Immunology 1992; 77: 136–143
   PubMedGoogle Scholar
• Irani A. M., Nilsson G., Miettinen U., Craig S. S., Ashman L. K., Ishizaka T., Zsebo K. M., Schwartz L. B. Recombinant human stem cell factor stimulates differentiation of mast cells from dispersed human fetal liver cells. Blood 1992; 80: 3009–3021
   PubMed Web of Science ®Google Scholar
• Galli S. J. New approaches for the analysis of mast cell maturation, heterogeneity, and function. Fed. Proc. 1987; 46: 1906–1914
   PubMedGoogle Scholar
• Chabot B., Stephenson D. A., Chapman V. M., Besmer P., Bernstein A. The proto-oncogene c-kit encoding a transmembrane tyrosine kinase receptor maps to the mouse W locus. Nature 1988; 335: 88–89
   PubMed Web of Science ®Google Scholar
• Geissler E. N., Ryan M. A., Housman D. E. The dominant-white spotting (W) locus of the mouse encodes the c-kit proto-oncogene. Cell 1988; 55: 185–192
   PubMed Web of Science ®Google Scholar
• Galli S. J., Zsebo K. M., Geissler E. N. The kit ligand, stem cell factor. Adv. Immunol. 1994; 55: 1–96
   PubMed Web of Science ®Google Scholar
• Witte O. N. Steel locus defines new multipotent growth factor: Minireview. Cell 1990; 63: 5–6
   PubMed Web of Science ®Google Scholar
• Tsai M., Takeishi T., Thompson H., Langley K. E., Zsebo K. M., Metcalfe D. D., Geissler E. N., Galli S. J. Induction of mast cell proliferation, maturation, and heparin synthesis by the rat c-kit ligand, stem cell factor. Proc. Natl. Acad. Sci. USA 1991; 88: 6382–6386
   PubMed Web of Science ®Google Scholar
• Adachi S., Ebi Y., Nishikawa S. I., Hayashi S. I., Yamazaki M., Kasugai T., Yamamura T., Nomura S., Kitamura Y. Necessity of extracellular domain of W (c-kit) receptors for attachment of murine cultured mast cells to fibroblasts. Blood 1992; 79: 650–656
   PubMed Web of Science ®Google Scholar
• Flanagan J. G., Leder P. The kit ligand: A cell surface molecule altered in steel mutant fibroblasts. Cell 1990; 63: 185–194
   PubMed Web of Science ®Google Scholar
• Aye M. T., Hashemi S., Leclair B., Zeibdawi A., Trudel E., Halpenny M., Fuller V., Cheng G. Expression of stem cell factor and c-kit messenger RNA in cultured endothelial cells, monocytes and cloned human bone marrow stromal cells (CFU-RF). Exp. Hematol. 1992; 20: 523–527
   PubMed Web of Science ®Google Scholar
• Irani A. M., Schechter N. M., Craig S. S., DeBlois G., Schwartz L. B. Two types of human mast cells that have distinct neutral protease compositions. Proc. Natl. Acad. Sci. 1986; 83: 4464–4468
   PubMed Web of Science ®Google Scholar
• Schecter N. M., Irani A. M., Sprows J. L., Abernethy J., Wintroub B., Schwartz L. B. Identification of a cathepsin G-like proteinase in the MCTC of human mast cell. J. Immunol. 1990; 145: 2652–2661
   Google Scholar
• Irani A. M., Goldstein S. M., Wintroub B. U., Bradford T., Schwartz L. B. Human mast cell carboxypeptidase: Selective localization to MCTC cells. J. Immunol. 1991; 147: 247–253
   Google Scholar
• Irani A. M. A., Craig S. S., DeBlois G., Elson C. O., Schechter N. M., Schwartz L. B. Deficiency of the tryptase-positive, chymase-negative mast cell type in gastrointestinal mucosa of patients with defective T lymphocyte function. J. Immunol. 1987; 138: 4381–4386
   Google Scholar
• Irani A. A., Gruber B. L., Kaufman L. D., Kahaleh M. B., Schwartz L. B. Mast cell changes in scleroderma. Presence of MCt cells in the skin and evidence of mast cell activation. Arthritis Rheum. 1992; 35: 933–939
   PubMedGoogle Scholar
• Schwartz L. B., Huff T. Biology of Mast Cells and Basophils. Allergy: Principles and Practice. Mosby, St Louis 1993
   Google Scholar
• Falanga V., Soter N. A., Altman R. D., Kerdel F. A. Elevated plasma histamine levels in systemic sclerosis (Scleroderma). Arch. Dermatol. 1990; 126: 336–338
   PubMedGoogle Scholar
• Russell J. D., Russell S. B., Trupin K. M. The effect of histamine on the growth of cultured fibroblasts isolated from normal and keloid tissue. J. Cell Physiol. 1977; 93: 389–393
   PubMedGoogle Scholar
• Hatamochi A., Ono M., Arakawa M., Takeda K., Ueki H. Analysis of collagen gene expression by cultured fibroblasts in morphea. Br. J. Dermatol. 1992; 126: 216–221
   Google Scholar
• Kalenderian R., Gruber B. L., Simon S., Gurtner G. H. Effects of histamine and heparin on human lung fibroblasts. Am. Rev. Resp. Dis. 1990; 42: A499
   Google Scholar
• Hakanson R., Owman C., Sjoberg N. O. Direct histochemistry demonstration of histamine in cutaneous mast cells. Experientia 1969; 25: 854–855
   Google Scholar
• Church M. K., Lowman M. A., Rees P. H., Benyon R. C. Plenary lecture. Mast cells, neuropeptides and inflammation 1989; 27: 8–16
   Google Scholar
• Pinckard R. N., McManus L. M., Hanahan D. J. Chemistry and Biology of Acetylglyceryl Ether Phosphorylcholine (Platelet Activating Factor). Raven Press, New York 1982, Advances in Inflammation Research Weismann G. 147160
   Google Scholar
• Archer C. B., Page C. P., Rougin R., Pfister A., Paul W., Morley J., MacDonald D. M. Inflammatory characteristics of platelet-activating factor (Paf-acether) in human skin. Br. J. Dermatol. 1984; 110: 45–51
   Google Scholar
• Wong D. T. W., Donoff B. R., Yang J. Sequential expression of transforming growth factors alpha and beta 1 by eosinophils during cutaneous wound healing in the hamster. Am. J. Pathol. 1993; 143: 130–142
   PubMed Web of Science ®Google Scholar
• Costa J. J., Matossian K., Resnick M. B., Beil W. J., Wong D. T., Gordon J. R., Dvorak A. M., Weller P. F., Galli S. J. Human eosinophils can express the cytokines tumor necrosis factor-alpha and macrophage inflammatory protein-1 alpha. J. Clin. Invest. 1993; 91: 2673–2684
   PubMedGoogle Scholar
• Schwartz L. B., Lewis R. A., Seldin D., Austen K. Acid hydrolases and tryptase from secretory granules of dispersed human lung mast cells. J. Immunol. 1981; 126: 1290–1294
   PubMed Web of Science ®Google Scholar
• Schwartz L. B., Lewis R. A., Austen K. F. Tryptase from human pulmonary mast cells: Purification and characterization. J. Biol. Chem. 1981; 256: 11939–11943
   PubMed Web of Science ®Google Scholar
• Schwartz L. B., Bradford T. R. Regulation of tryptase from human lung mast cells by heparin: Stabilization of the active tetramer. J. Biol. Chem. 1986; 261: 7372–7379
   PubMed Web of Science ®Google Scholar
• Miller J. S., Westin E. H., Schwartz L. B. Cloning and characterization of complementary DNA for human tryptase. J. Clin. Invest. 1989; 84: 1188–1195
   PubMed Web of Science ®Google Scholar
• Miller J. S., Moxley G., Schwartz L. B. Cloning and characterization of a second complementary DNA for human tryptase. J. Clin. Inst. 1990; 86: 864–870
   PubMed Web of Science ®Google Scholar
• Vanderslice P., Ballinger S. M., Tarn E. K., Goldstein S. M., Craig C. S., Caughey G. H. Human mast cell tryptase—Multiple cDNAs and genes reveal a multigene serine protease family. Proc. Natl Acad. Sci. USA 1990; 87: 3811–3815
   PubMed Web of Science ®Google Scholar
• Smith T. J., Houghland M. W., Johnson D. A. Human lung tryptase, purification and characterization. J. Biol. Chem. 1984; 259: 11046–11051
   PubMedGoogle Scholar
• Schwartz L. B., Metcalfe D. D., Miller J. S., Earl H., Sullivan T. Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis. N. Engl. J. Med. 1987; 316: 1622–1626
   PubMed Web of Science ®Google Scholar
• Schwartz L. B., Yunginger J. W., Miller J., Bokhari R., Dull D. Time course of appearance and disappearance of human mast cell tryptase in the circulation after anaphylaxis. J. Clin. Invest. 1989; 83: 1551–1555
   PubMed Web of Science ®Google Scholar
• Alter S. C., Kramps J. A., Janoff A., Schwartz L. B. Interactions of human mast cell tryptase with biological protease inhibitors. Arch. Biochem. Biophys. 1990; 276: 26–31
   PubMedGoogle Scholar
• Gruber B. L., Schwartz L. B., Ramamurthy N. S., Irani A. M., Marchese M. J. Activation of latent rheumatoid synovial collagenase by human mast cell tryptase. J. Immunol. 1988; 140: 3936–3942
   PubMed Web of Science ®Google Scholar
• Caughey G. H., Leidig R., Viro N. R., Nadel J. A. Substance P and vasoactive intestinal peptide degradation by mast cell tryptase and chymase. J. Pharmacol. Exp. Ther. 1988; 244: 133–137
   PubMed Web of Science ®Google Scholar
• Walls A. R., Brain S. D., Desai A., Jose P. J., Hawkings E., Church M. K., Williams T. J. Human mast cell tryptase attenuates the vasodilator activity of calcitonin gene-related peptide. Biochem. Pharmacol. 1992; 43: 1243–1248
   PubMed Web of Science ®Google Scholar
• Ruoss S. J., Hartmann T., Caughey G. H. Mast cell tryptase is a mitogen for cultured fibroblasts. J. Clin. Invest. 1991; 88: 493–499
   PubMed Web of Science ®Google Scholar
• Hartmann T., Ruoss S. J., Raymond W. W., Seuwen K., Caughey G. H. Human tryptase as a potent, cell-specific mitogen: Role of signaling pathways in synergistic responses. Am. J. Physiol. 1992; 262: L528–L534
   Google Scholar
• Urata H., Kinoshita A., Perez D. M., Misono K. S., Bumpus R M., Graham R. M., Husain A. Cloning of the gene and cDNA for human heart chymase. J. Biol. Chem. 1991; 266: 17173–17179
   PubMed Web of Science ®Google Scholar
• Caughey G. H., Schaumberg T. H., Zerweck E. H., Butterfield J. H., Hanson R. D., Silverman G. A., Ley T. J. The human mast cell chymase gene (CMA1) Mapping to the cathepsin G/granzyme gene cluster and lineage-restricted expression. Genomics 1993; 15: 614–620
   Google Scholar
• Vartio T., Seppa H., Vaheri A. Susceptibility of soluble and matrix fibronectins to degradation by tissue proteinases, mast cell chymase and cathepsin G. J. Biol. Chem. 1981; 256: 471–476
   PubMedGoogle Scholar
• Wintroub B. U., Schecter N. M., Lazarus G. S., Kaempfer C. E., Schwartz L. B. Angiotensin I conversion by human and rat chymotryptic proteinases. J. Invest. Dermatol. 1984; 83: 336–339
   PubMed Web of Science ®Google Scholar
• Sayama S., Lozzo R. V., Lazarus G. S., Schechter N. M. Human skin chymotrypsin-like proteinase chymase. J. Biol. Chem. 1987; 262: 6808–6815
   Google Scholar
• Schechter N. M., Choi J. K., Slavin D. A., Deresienski D. T., Sayama S., Dong G., Lavker R. M., Proud D., Lazarus G. S. Identification of a chymotrypsin-like proteinase in human mast cells. J. Immunol. 1986; 137: 962–970
   Google Scholar
• Briggaman R. A., Schechter N. M., Fraki J., Lazarus G. S. Degradation of the epidermal-dermal junction by proteolytic enzymes from human skin and human polymorphonuclear leukocytes. J. Exp. Med. 1984; 160: 1027–1042
   PubMed Web of Science ®Google Scholar
• Rubinstein I., Nadel J. A., Graf P. D., Caughey G. H. Mast cell chymase augments histamine-induced wheal formation in allergic dog skin. FASEB J. 1990; 4: A1939
   Google Scholar
• Mizutani H., Schechter N., Lazarus G., Black R. A., Kupper T. S. Rapid and specific conversion of precursor interleukin 1β (IL-1β) to an active IL-1 species by human mast cell chymase. J. Exp. Med. 1991; 174: 821–825
   PubMed Web of Science ®Google Scholar
• Wypij D. M., Nichols J. S., Novak P. J., Stacy D. L., Berman J., Wiseman J. S. Role of mast cell chymase in the extracellular processing of big-endothelin-1 to endothelin-1 in the perfused rat lung. Biochem. Pharmacol. 1992; 43: 845–853
   PubMed Web of Science ®Google Scholar
• Natsuaki M., Stewart C. B., Vanderslice P., Schwartz L. B., Natsuaki M., Winthroub B. U., Rutter W. J., Goldstein S. M. Human skin mast cell carboxypeptidase: Functional characterization, cDNA cloning, and genealogy. J. Invest. Dermatol. 1992; 99: 138–145
   Google Scholar
• Krejci N. C., M K. D., Rudd R. J., Bauer E. A., McGuire J. Dermal mast cell granules bind interstitial procollagenase and collagenase. J. Invest. Derm. 1992; 98: 748–752
   PubMed Web of Science ®Google Scholar
• Stevens R. L., Fox C. C., Lichtenstein L. M., Austen K. F. Identification of chondroitin sulfate E proteoglycans and heparin proteoglycans in the secretory granules of human lung mast cells. Proc. Natl. Acad. Sci. USA 1988; 85: 2284–2287
   PubMed Web of Science ®Google Scholar
• Metcalfe D. D., Lewis R. A., Silbert J. E. Isolation and characterization of heparin from human lung. J. Clin. Invest. 1979; 64: 1537–1543
   PubMed Web of Science ®Google Scholar
• Razin E., Stevens R. L., Akiyama F. Culture from mouse bone marrow of a subclass of mast cells possessing a distinct chondroitin sulfate proteoglycan with glycosaminoglycans rich in N-acetylgalac-tosamine-4, 6-disulfate. J. Biol Chem. 1982; 257: 7229–7236
   PubMed Web of Science ®Google Scholar
• Ruoslahti E. Proteoglycans in cell regulation. Cell 1989; 264: 13369–13372
   Google Scholar
• Yamaguchi Y., Mann D. M., Ruoslahti E. Negative regulation of TGF-β by the proteoglycan decorin. Nature 1990; 346: 281–284
   PubMed Web of Science ®Google Scholar
• Rosenberg R. D. Biological actions of heparin. Semin. Hematol. 1977; 14: 427–440
   PubMed Web of Science ®Google Scholar
• Lonky S. A., Marsh J., Wohl H. Stimulation of human granulocyte elastase by platelet factor 4 and heparin. Biochem. Biophys. Res. Commun. 1978; 85: 1113–1118
   PubMedGoogle Scholar
• Gajdusek C. Release of endothelial cell-derived growth factor (ECDGF) by heparin. J. Cell Physiol. 1984; 121: 13–21
   Google Scholar
• Gospodarwicz D., Cheng J. Heparin protects basic and acidic FGF from inactivation. J. Cell Physiol. 1986; 128: 475–484
   Google Scholar
• McCaffrey T. A., Falcone D. J., Brayton C. F., Agarwal L. A., Welt F. G., Weksler B. B. Transforming growth factor-beta activity is potentiated by heparin via dissociation of the transforming growth factor-beta/alpha 2-macroglobulin inactive complex. J. Cell Biol. 1989; 109: 441–448
   PubMed Web of Science ®Google Scholar
• Schreiber A. B., Kenney J., Kowalski W. J., Frisel R., Mehlman T., Maciag T. Interaction of endothelial cell growth factor with heparin: Characterization by receptor and antibody recognition. Proc. Natl. Acad. Sci. USA 1985; 82: 6138–6142
   PubMed Web of Science ®Google Scholar
• Meininger C: J., Sherwood S. J., Hawker J. R. Mast cell heparin displaces with basic fibroblast growth factor from endothelial cell matrix. J. Cell Biochem. 1991; 15, (Suppl.)(Abstract)
   Google Scholar
• Wright T. C. J., Pukac L. A., Castellot J. J. J., Karnovsky M. J., Levine R. A., Kim-Park H. Y., Campisi J. Heparin suppresses the induction of c-fos and c-myc mRNA in murine fibroblasts by selective inhibition of a protein kinase C-dependent pathway. Proc. Natl. Acad. Sci. USA 1989; 86: 3199–3203
   PubMedGoogle Scholar
• Kenagy R. D., Nikkari S. T., Welgus H. G., Clowes A. W. Heparin inhibits the induction of three matrix metalloproteinases (stromelysin, 92-kD gelatinase, and collagenase) in primate smooth muscle cells. J. Clin. Invest. 1994; 93: 1987–1993
   PubMed Web of Science ®Google Scholar
• Weiler J. M., Yurt R. W., Fearon D. T., Austen K. F. Modulation of the formation of the amplification convertase of complement, C3b, Bb, by native and commercial heparin. J. Exp. Med. 1978; 147: 409–421
   PubMed Web of Science ®Google Scholar
• Kazatchkine M. D., Pearson D. T., Silbert J. E., Austen K. F. Surface-associated heparin inhibits zymosan-induced activation of the human alternative complement pathway by augmenting the regulatory action of the control proteins on particle-bound C3b. J. Exp. Med. 1979; 150: 1202–1215
   PubMed Web of Science ®Google Scholar
• Avioli L. V. Heparin induced osteopenia: An appraisal. Adv. Exp. Med. Biol. 1975; 52: 375–387
   PubMedGoogle Scholar
• Crisp A. J., Wright J. K., Hazleman B. L. Effects of heparin, histamine, and salmon calcitonin on mouse calvarial bone resorption. Ann. Rheum. Dis. 1986; 45: 422–427
   Google Scholar
• Glowacki J. The effects of heparin and protamine on resorption of bone particles. Life Sci. 1983; 33: 1019–1024
   PubMed Web of Science ®Google Scholar
• Goldhaber P. Heparin enhancement of factors stimulating bone resorption in tissue culture. Science 1965; 147: 407–408
   PubMedGoogle Scholar
• Hurley M. M., Gronowicz G., Kream B. E., Raisz L. G. Effect of heparin on bone formation in cultured fetal rat calvaria. Calcif. Tissue Internal. 1990; 46: 183–188
   Google Scholar
• Sakamoto S., Sakamoto M., Goldhaber P., Glimcher M. J. Studies on the interaction between heparin and mouse bone collagenase. Biochim. Biophys. 1975; 385: 41–50
   PubMedGoogle Scholar
• Yamashita Y., Nakagomi K., Hasegawa S., Mitsui Y. Effect of heparin on proliferation of pulmonary fibroblasts. Am. Rev. Resp. Dis. 1990; 42: A912
   Google Scholar
• Sanantonio J. D., Lander A. D., Wright T. C., Karnovsky M. J. Heparin inhibits the attachment and growth of BALB/C-3T3 fibroblasts on collagen substrata. J. Cell Physiol. 1992; 150: 8–16
   Google Scholar
• Burd P. R., Rogers H. W., Gordon J. R., Martin C. A., Jayaraman S., Wilson S. D., Dvorak A. M., Galli S. J., Dorf M. E. Interleukin 3-dependent and-independent mast cells stimulated with IgE antigen express multiple cytokines. J. Exp. Med. 1989; 170: 245–254
   PubMed Web of Science ®Google Scholar
• Tsai M., Gordon J. R., Galli S. J. Mast cells constitutively express transforming growth factor-beta mRNA. FASEB J. 1990; 4: A1944
   Google Scholar
• Gordon J. R., Burd P. R., Galli S. J. Mast cells as a source of multifunctional cytokines. Immunol. Today 1990; 11: 458–464
   PubMedGoogle Scholar
• Plaut M., Pierce J. H., Watson C. J., Hanley-Hyde J., Nordan R. P., Paul W. E. Mast cell lines produce lymphokines in response to cross-linkage of Fc epsilon RI or to calcium ionophores. Nature 1989; 339: 64–67
   PubMed Web of Science ®Google Scholar
• Young J., Lice C. C., Butler G., Cohn Z. A., Galli S. J. Identification, purification, and characterization of a mast cell-associated cytolytic factor related to tumor necrosis factor. Proc. Natl. Acad. Sci. USA 1987; 84: 9175–9179
   PubMed Web of Science ®Google Scholar
• Ohkawara Y., Yamauchi K., Tanno Y., Tamura G., Ohtani H., Nagura H., Ohkuda K., Takishima T. Human lung mast cells and pulmonary macrophages produce tumor necrosis factor-alpha in sensitized lung tissue after IgE receptor triggering. Am. J. Respir. Cell Mol. Biol. 1992; 7: 385–392
   PubMed Web of Science ®Google Scholar
• Butterfield J. H., Weiler D., Dewald G., Gleich G. J. Establishment of an immature mast cell line from a patient with mast cell leukemia. Leukemia Res. 1988; 12: 345–355
   PubMed Web of Science ®Google Scholar
• Moller A., Lippert D., Lessman D., Kolde G., Hamann K., Welker P., Schadendorf D., Rosenbach T., Luger T., Czarnetzki B. M. Human mast cells produce IL-8. J. Immunol. 1993; 151: 3261–3266
   PubMed Web of Science ®Google Scholar
• Galli S. J., Gordon J. R., Wershil B. K. Mast cell cytokines in allergy and inflammation. Agents Actions Suppl. 1993; 43: 209–220
   Google Scholar
• Selvan R. S., Butterfield J. H., Krangel M. S. Expression of multiple chemokine genes by human mast cell leukemia. J. Biol. Chem. 1994; 269: 13893–13898
   PubMed Web of Science ®Google Scholar
• Bradding P., Feather I. H., Howarth P. H. Interleukin 4 is localized to and released by human mast cells. J. Exp. Med. 1992; 176: 1381–1386
   PubMed Web of Science ®Google Scholar
• Steffen M., Abboud M., Potter G. K., Young Y. P., Moore M. A. S. Presence of tumor necrosis factor or related factor in human basophil/mast cells. Immunology 1989; 66: 445–450
   PubMedGoogle Scholar
• Walsh L. J., Trinchieri G., Waldorf H. A., Whitaker D., Murphy G. F. Human dermal mast cells contain and release tumor necrosis factor a, which induces endothelial leukocyte adhesion molecule 1. Proc. Natl. Acad. Sci. USA 1991; 88: 4220–4224
   PubMed Web of Science ®Google Scholar
• Banovac K., Neylan D., Leone J., Ghandur-Mnaymneh L., Rabinovitch A. Are the mast cells antigen presenting cells?. Immunol. Invest. 1989; 18: 901–906
   PubMed Web of Science ®Google Scholar
• Fleischmajer R., Perlish J. S., Reeves J. R. T. Cellular infiltrates in scleroderma skin. Arthritis Rheum. 1977; 20: 975–984
   PubMed Web of Science ®Google Scholar
• Nishioka K., Kobayashi Y., Katayama I., Takijiri K. Mast cell numbers in diffuse scleroderma. Arch. Dermatol. 1987; 123: 205–208
   PubMedGoogle Scholar
• Hawkins R. A., Daman H. N., Clark R. A. P., Steigerwald J. C. Increased dermal mast cell populations in progressive systemic sclerosis: A link in chronic fibrosis?. Ann. Intern. Med. 1985; 102: 182–186
   PubMed Web of Science ®Google Scholar
• Takeda K., Hatamochi A., Ueki H. Increased number of mast cells accompany enhanced collagen synthesis in linear localized scleroderma. Arch. Dermatol. Res. 1989; 281: 288–290
   Google Scholar
• Lichtbroun A. S., Sandhaus L. M., Giorno R. C., Kim H., Seibold J. R. Myocardial mast cells in systemic sclerosis: A report of three fatal cases. Am. J. Med. 1990; 89: 372–376
   PubMedGoogle Scholar
• Claman H. N. Mast cells, T cells and abnormal fibrosis. Immunol. Today 1985; 6: 192–194
   Google Scholar
• Claman H. N. Mast cell changes in a case of rapidly progressive scleroderma: Ultrastructural analysis. J. Invest. Derm. 1989; 92: 290–295
   PubMed Web of Science ®Google Scholar
• Claman H. N., Lee Choi K., Sujansky W., Vatter A. E. Mast cell “disappearance” in chronic murine graft-vs-host disease (GVHD)—Ultrastructural demonstration of “phantom mast cells”. J. Immunol. 1986; 137: 2009–2013
   PubMed Web of Science ®Google Scholar
• Kirkpatrick C. J., Curry A. Interaction between mast cells and perineural fibroblasts in neurofibroma: New insights into mast cell function. Path. Res. Pract. 1988; 183: 453–458
   PubMed Web of Science ®Google Scholar
• Kawanami O., Ferrans V. J., Fulmer J. D., Crystal R. G. infrastructure of pulmonary mast cells in patients with fibrotic lung disorders. Lab. Invest. 1979; 40: 717–734
   PubMed Web of Science ®Google Scholar
• Gabrielli A., DeNictolis M., Campanati G., Cinti S. Eosinophilic fasciitis: A mast cell disorder?. Clin. Exp. Rheumatol. 1983; 1: 75–78
   PubMedGoogle Scholar
• Kirscher C. W., Bailey J. F. The mast cell in hypertrophic scars. Tex. Rep. Biol. Med. 1972; 30: 327–338
   Google Scholar
• Severson A. R. Mast cells in areas of experimental bone resorption and remodelling. Br. J. Exp. Pathol. 1969; 50: 17–21
   PubMedGoogle Scholar
• Walls A. E., Bennett A. R., Godfrey R. C., Holgate S. T., Church M. K. Mast cell tryptase and histamine concentrations in bronchoalveolar lavage fluid from patients with interstitial lung disease. Clin. Sci. 1991; 81: 183–188
   Google Scholar
• Norrby K., Amqvist H. J., Bergstrom S., Druvefors P. Augmented mitogenesis in normal connective tissue cells following mast cell secretion in diabetic rats. Virchows Arch. (Cell Pathol.) 1982; 39: 139–144
   Google Scholar
• Norrby K. Intradermal mast-cell secretion causing cutaneous mitogenesis. Virchows Arch. (Cell Pathol.) 1983; 42: 263–269
   Web of Science ®Google Scholar
• Walker M. A., Harley R., Maise J., DeLustro E., LeRoy E. C. Mast cells and their degranulation in the Tsk mouse model of scleroderma. Proc. Soc. Exp. Biol. Med. 1985; 180: 323–328
   PubMedGoogle Scholar
• Claman H. N., Jaffee B. D., Huff J. C., Clark R. A. F. Chronic graft-versus-host disease (GVHD) as a model for scleroderma, II: Mast cell depletion with deposition of immunoglobulins in the skin and fibrosis. Cell Immunol. 1985; 94: 73–84
   PubMed Web of Science ®Google Scholar
• Seibold J. R., Giorno R. C., Claman H. N. Dermal mast cell degranulation in systemic sclerosis. Arthritis Rheum. 1990; 33: 1702–1709
   PubMedGoogle Scholar
• Allen J. B., Manthey C. L., Hand A. R., Ohura K., Ellingsworth L., Wahl S. M. Rapid onset synovia! inflammation and hyperplasia induced by transforming growth factor beta. J. Exp. Med. 1990; 171: 231–247
   PubMed Web of Science ®Google Scholar
• Baeza M. L., Reddigari S. R., Kornfeld D., Ramani N., Smith E. M., Hossler P. A., Fischer T., Castor C. W., Gorevic P. G., Kaplan A. P. Relationship of one form of human histamine releasing factor (HRF) to connective tissue activating peptide-III (CTAP-III). J. Clin. Invest. 1990; 85: 1516–1521
   Google Scholar
• Levi-Schaffer E., Austen K. E., Gravallese P. M., Stevens R. L. Co-culture of interleukin 3-dependent mouse mast cells with fibroblasts results in a phenotypic change of the mast cells. Proc. Natl. Acad. Sci. USA 1986; 83: 6485–6488
   PubMed Web of Science ®Google Scholar
• Levi-Schaffer F., Kupietzky A. Mast cells enhance migration and proliferation of fibroblasts into an in vitro wound. Exp. Cell Res. 1990; 188: 42–49
   PubMed Web of Science ®Google Scholar
• Subba Rao P. V., Friedman M. M., Atkins F. M., Metcalfe D. D. Phagocytosis of mast cell granules by cultured fibroblasts. J. Immunol. 1983; 130: 341–349
   PubMed Web of Science ®Google Scholar
• Ginsburg H., Amira M., Padawer J., Davidson S. Structural alterations in fibroblast monolayers caused by mast cell degranulation. J. Leukocyte Biol 1989; 45: 491–497
   Google Scholar
• Levi-Schaffer F., Riesel N. In vitro regeneration of activated rat peritoneal mast cells cocultured with 3T3 fibroblasts. Cell Immunol. 1989; 119: 30–40
   Google Scholar
• Cohen I. K., Beaven M. A., Horakova K., Keiser H. R. Histamine and collagen synthesis in keloid and hypertrophic scars. Surg. Forum 1972; 23: 509–510
   Google Scholar
• Hatamochi A., Fujiwara K., Ueki H. Effects of histamine on collagen synthesis by cultured fibroblasts derived from guinea pig skin. Arch. Dermatol. Res. 1985; 277: 60–64
   PubMed Web of Science ®Google Scholar
• Barzu T., Molho P., Tobelem G., Petitou M., Caen J. Binding and endocytosis of heparin by human endothelial cells in culture. Biochim. Biophys. Ada 1985; 845: 196–203
   Google Scholar
• Dahodwala I., Schulman E. S., Raible D. G., Post T. J., Scavecchio K. Histamine and human lung mast cell supernatants stimulate human fibroblast proliferation. FASEB 1990; 4: A1941
   Google Scholar
• Pennington D. W., Lopez A. R., Gold W. M. Mastocytoma cells produce a growth factor for fibroblasts which is not histamine. Clin. Res. 1990; 38: 159, (Abstract)
   Google Scholar
• Pennington D. W., Lopez A. R., Gold W. M. Transforming growth factor-beta secretion by four dog mastocytoma cell lines. Am. Rev. Resp. Dis. 1990; 42: A498
   Google Scholar
• Norrby K., Enerbäck L., Franzén L. Mast cell activation and tissue cell proliferation. Cell Tissue Res. 1976; 170: 289–303
   PubMed Web of Science ®Google Scholar
• Norrby K. On the 48/80-induced secretion of tissue mast cells and its mitogenic effect on nearby cells in the intact rat. Virchows Arch. (Cell Path.) 1981; 38: 57–65
   Web of Science ®Google Scholar
• Macnaul K. L., Chartrain N., Lark M., Tocci M. J., Hutchinson N. I. Discoordinate expression of stromelysin, collagenase, and tissue inhibitor of metalloproteinases-1 in rheumatoid human synovial fibroblasts—Synergistic effects of interleukin-1 and tumor necrosis factor-alpha on stromelysin expression. J. Biol. Chem. 1990; 265: 17238–17245
   PubMed Web of Science ®Google Scholar
• Yoffe J., Taylor D. J., Woolley D. E. Mast cell products stimulate collagenase and prostaglandin E production by cultures of adherent rheumatoid synovial cells. Biochem. Biophys. Res. Comm. 1984; 122: 270–276
   Google Scholar
• Groto T., Befus D., Low R., Bienenstock J. Mast cell heterogeneity and hyperplasia in bleomycin-induced pulmonary fibrosis in rats. Am. Rev. Resp. Dis. 1984; 130: 797–802
   Google Scholar
• Horucki T., Ohta K., Yamaguchi M. Mast cell involvement in bleomycin induced lung injury of mice. Am. Rev. Resp. Dis. 1990; 42: A498
   Google Scholar
• O'Brien-Ladner A., Wesselius L. J., Stechshulte D. J. Decreased lung collagen deposition in mast cell deficient mice after bleomycin. Am. Rev. Resp. Dis. 1990; 42: A499
   Google Scholar
• Suzuki N., Horiuchi T., Ohta K., Yamaguchi M., Ueda T., Takizawa H., Hirai K., Shiga J., Ito K., Miyamoto T. Mast cells are essential for the full development of silica-induced pulmonary inflammation: A study with mast cell-deficient mice. Am. J. Resp. Cell Mol. Biol. 1993; 9: 475–483
   PubMed Web of Science ®Google Scholar
• Rafii M., Firooznia H., Golimbu C., Balthazar E. Pathologic fracture in systemic mastocytosis. Radiographic spectrum and review of the literature. Clin. Orthop. 1983; 180: 260–267
   PubMed Web of Science ®Google Scholar
• Gruber B. L., Kaufman L. D. Remission in progressive early diffuse scleroderma induced by ketotifen: Evidence for the role of mast cells in disease pathogenesis. Am. J. Med. 1990; 89: 392–395
   Google Scholar
• Walker M. A., Harley R. A., LeRoy E. C. Inhibition of fibrosis in Tsk mice by blocking mast cell degranulation. J. Rheumatol. 1987; 14: 299–301
   Google Scholar
• Walker M., Harley R., LeRoy E. C. Ketotifen prevents skin fibrosis in the TSK/+ mouse. J. Rheumatol. 1990; 17: 57–59
   Google Scholar
• Gruber B. L., Kaufman L. D. A double-blind randomized controlled trial of ketotifen versus placebo in early diffuse scleroderma. Arthritis Rheum. 1990; 34: 362–366
   Google Scholar